George G Holz Selected Research

Hyperglycemia

12/2022	GTS-21, a selective alpha7 nicotinic acetylcholine receptor agonist, ameliorates diabetic nephropathy in Leprdb/db mice.
4/2008	Cytosolic adenylate kinases regulate K-ATP channel activity in human beta-cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

George G Holz Research Topics

Disease

14	Type 2 Diabetes Mellitus (MODY) 11/2023 - 11/2003
6	Obesity 12/2023 - 01/2018
3	Nausea 01/2021 - 01/2018
3	Vomiting 01/2021 - 01/2020
3	Anorexia 01/2021 - 01/2018
3	Diabetes Mellitus 11/2003 - 02/2002
2	Hypoglycemia (Reactive Hypoglycemia) 12/2023 - 03/2010
2	Weight Loss (Weight Reduction) 12/2023 - 01/2021
2	Body Weight (Weight, Body) 12/2023 - 01/2022
2	Inflammation (Inflammations) 12/2022 - 12/2020
2	Hyperglycemia 12/2022 - 04/2008
2	Neoplasms (Cancer) 03/2022 - 01/2020
1	Diabetic Nephropathies (Diabetic Nephropathy) 12/2022
1	Insulin Resistance 01/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2020
1	Body Weight Changes 01/2018
1	Insulinoma 09/2006

Drug/Important Bio-Agent (IBA)

9	Glucagon-Like Peptide 1 (GLP 1)IBA 12/2023 - 02/2002
6	Glucose (Dextrose)FDA LinkGeneric 12/2023 - 04/2008
5	Blood Glucose (Blood Sugar)IBA 01/2018 - 03/2003
4	Glucagon (Glukagon)FDA Link 12/2023 - 11/2003
4	Insulin (Novolin)FDA Link 12/2023 - 02/2002
4	Hormones (Hormone)IBA 12/2023 - 02/2002
4	Exenatide (Byetta)FDA Link 01/2021 - 03/2010
4	Glucagon-Like Peptide-1 ReceptorIBA 01/2020 - 11/2011
3	Peptides (Polypeptides)IBA 12/2023 - 01/2018
3	erythromycin propionate-N-acetylcysteinateIBA 10/2018 - 03/2003
2	Liraglutide FDA Link 12/2023 - 11/2011
2	3-(2,4-dimethoxybenzylidene)anabaseineIBA 12/2022 - 01/2022
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 12/2022 - 12/2020
2	Cholecystokinin (Pancreozymin)IBA 03/2022 - 01/2020
2	GastrinsIBA 03/2022 - 01/2020
2	Glucagon-Like Peptide-1 Receptor AgonistsIBA 11/2011 - 11/2003
2	Adenosine Triphosphate (ATP)IBA 03/2010 - 04/2008
1	Peptide YYIBA 12/2023
1	NeuropeptidesIBA 12/2023
1	neuropeptide Y2 receptorIBA 12/2023
1	alpha7 Nicotinic Acetylcholine ReceptorIBA 12/2022
1	Interleukin-6 (Interleukin 6)IBA 12/2022
1	Cholinergic Agents (Cholinergics)IBA 12/2022
1	HMGB1 Protein (HMG1)IBA 12/2022
1	Leptin ReceptorsIBA 12/2022
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 03/2022
1	Chelating AgentsIBA 03/2022
1	1- (1,3- carboxypropyl)- 4,7- carboxymethyl- 1,4,7- triazacyclononaneIBA 03/2022
1	Sitagliptin Phosphate (Januvia)FDA Link 01/2022
1	carboxyaminoimidazole ribotide (CAIR)IBA 12/2020
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 01/2018
1	Proglucagon (Glucagon Precursors)IBA 06/2016
1	2- (2- (4- bromophenyl)- 6- methylpyrimidin- 4- yl)aminoethanolIBA 06/2016
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2014
1	Indicators and Reagents (Reagents)IBA 09/2006
1	Fura-2 (Fura 2)IBA 09/2006

Therapy/Procedure

2	Glycemic Control 12/2023 - 01/2020
2	Precision Medicine 03/2022 - 01/2020
2	Therapeutics 01/2021 - 01/2020